The Hammersmith campus Athena lecture is open to all those at Hammersmith, and also all members of NHLI from other campuses.
The lecture will be followed by a networking social at ICTEM – register here
Biography
Rosenthal’s research uses mammalian genetics to explore the embryonic development of heart and skeletal muscle and the regeneration of adult tissues. She focuses on muscle and cardiac developmental genetics and the role of growth factors, stem cells and the immune system in tissue regeneration.
She is a global leader in the use of targeted mutagenesis in mice to investigate muscle development, disease and repair, and is a participant in EUCOMM, the European Conditional Mouse Mutagenesis Program, where she coordinates the selection and production of new Cre driver strains for the international mouse genetics community.
After earning her Ph.D. in biochemistry at Harvard Medical School, she started collaborating with JAX researchers, developing her longstanding focus on mammalian genetics using the mouse as model. As her career progressed, through faculty appointments at Harvard Medical School and Boston University School of Medicine, Rosenthal’s network with the JAX faculty and Board of Trustees continued to grow. In 2001 Rosenthal moved to Rome to establish the mouse biology program for the European Molecular Biology Laboratory (EMBL).
While maintaining leadership of the EMBL program, Rosenthal joined Imperial College, London in 2005 as Director of Science for the Harefield Heart Science Centre and Chair in Cardiovascular Science, and in 2009 established ARMI at Monash University, which now leads Australia in biomedical research grants. She established the first non-European membership in EMBL for Australia, coordinating partner laboratories around the country, and was elected Scientific Head of EMBL Australia in 2010. She joined The Jackson Laboratory’s Board of Scientific Counsellors in 2011, before becoming Scientific Director in 2015.